Home›Stock Screener›Trimurthi

Trimurthi Share Price Today | Stock Price & Trimurthi Share Screener

NOVELIX Pharmacy Retail
Live Share Price BSE
₹66.23
▼ -3.77 (-5.39%)
2026-10-05 00:00:00

As of October 5, 2026, the live Trimurthi share price (BSE: NOVELIX) is ₹66.23, down 5.39% from the previous close, with shares trading between ₹65.00 and ₹73.97 in today's trading session, and a 52-week range of ₹45.30–₹88.80. Check Trimurthi yearly highs lows for the annual price range and momentum. Use the Trimurthi stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Trimurthi opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1 and net income of ₹-2, with EBITDA of ₹-2, an operating margin of -236.0% and a profit margin of -200.0%.

Trimurthi Market Cap ₹199.32 Cr.
NOVELIX P/E Ratio (TTM) 15.00
Trimurthi P/B Ratio 5.63
EPS (TTM) ₹-2.22
Dividend Yield -
Debt to Equity 0.01
NOVELIX 52 Week High ₹88.80
Trimurthi 52 Week Low ₹45.30
Operating Margin -236.00%
Profit Margin -200.00%
NOVELIX Revenue (TTM) ₹1.00
EBITDA ₹-2.00
Net Income ₹-2.00
Total Assets ₹9.00
Total Equity ₹8.00

Trimurthi Share Price Chart

Track the current stock price of Trimurthi with an interactive chart. Analyse NOVELIX share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Trimurthi stock quote in one place.

The quote of ₹66.23 sits between the 52-week low of ₹45.30 and the 52-week high of ₹88.80, and the latest session moved -5.39% from the previous close.

Trimurthi Company Profile - Fundamental Screener

Screen Trimurthi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NOVELIX shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Retail sector and the Pharmacy Retail industry, and it trades under ISIN INE314I01036.

Company Details

Classification

Sector Retail
Industry Pharmacy Retail
Sub-Sector Pharmacy Retail
Segment E

Identifiers and Leadership

ISIN INE314I01036

Trimurthi Balance Sheet Screener

Screen NOVELIX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2022, total assets were ₹9, down from ₹10 in 2021.

Latest statistics put total assets at ₹9 and shareholder funds at ₹8, with a leverage ratio of 0.01.

Item 2022 2021 2020 2019 2018 2017 2016 2015

Assets

Total Assets 9 10 14 13 14 14 13 13
Current Assets 6 7 11 11 11 11 11 10
Fixed Assets 2 2 2 2 2 2 1 1

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 0 0 1 1 1 1 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 8 7 11 11 12 12 12 12
Share Capital 8 8 8 8 8 8 8 8
Reserves & Surplus -1 -1 3 3 3 3 4 3

Trimurthi Income Statement Screener - Profit & Revenue Analysis

Screen Trimurthi income statement and profit fundamentals. Analyze NOVELIX quarterly results. Trimurthi reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2022-Mar, revenue was ₹1 and net profit was ₹-2, equal to earnings per unit of ₹-1.67, at an operating margin of -236%.

In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2022-Jun, shows revenue of ₹1 and net profit of ₹0.

Item 2022-Mar 2022-Jun 2022-Sept 2021-Mar 2021-Jun 2021-Sept 2021-Dec 2020-Mar 2020-Jun 2020-Sept 2020-Dec 2019-Mar 2019-Jun 2019-Sept 2019-Dec

Revenue and Expenses

Revenue 1 1 1 3 5 3 1 3 2 3 2 3 3 3 3
Expenses 2 2 1 6 5 2 2 3 2 3 3 3 2 3 3

Operating Costs and Margins

EBITDA -2 0 0 -3 0 1 -1 0 0 0 0 0 0 0 0
Operating Profit % -236.00% -11.00% -15.00% -130.00% -4.00% 6.00% -87.00% -4.00% -7.00% -6.00% -12.00% -5.00% 3.00% -12.00% -7.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax -2 0 0 -3 0 0 -1 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -2 0 0 -3 0 0 -1 0 0 0 0 0 0 0 0
EPS -1.67 -0.11 -0.19 -4.05 -0.18 0.39 -0.77 0.04 -0.11 -0.21 -0.26 0.06 -0.03 -0.21 -0.14

Trimurthi Cash Flow Screener - Liquidity Fundamentals

Screen NOVELIX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2022-March, operating activities generated ₹2, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹1 and financing activities provided ₹0.

Item 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Cash from Operations and Investing

Operating Activities 2 2 1 -1 0 -2 2 0
Investing Activities -1 0 0 0 -1 0 -1 -1

Financing and Net Cash

Financing Activities 0 -1 0 0 0 1 0 0
Net Cash Flow 1 1 1 0 0 -1 1 -1

Trimurthi Shareholding Pattern Screener

See Trimurthi shareholding pattern with promoter, FII, and DII holdings. Check Trimurthi promoter holding and ownership changes for NOVELIX on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 50.80%, foreign institutions 0.00%, domestic institutions 0.00% and the public 44.00%, spread across 2,994 shareholders.

The shareholder count was 2,994 in 2026-Jan, compared with 3,029 in 2026-Feb.

Item 2026-Jan 2026-Feb 2026-Mar 2026-Jun 2026-Jul 2025-Mar 2025-Jun 2025-Aug

Promoter Holding

Promoter Holding 50.80% 46.51% 49.43% 50.57% 54.29% 66.56% 52.75% 53.33%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 44.00% 48.88% 46.42% 45.71% 41.88% 20.06% 36.84% 38.98%
Other Holding 5.21% 4.60% 4.15% 3.72% 3.83% 13.38% 10.42% 7.69%
Shareholder Count 2,994 3,029 2,975 3,004 3,127 2,484 2,481 2,754

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Trimurthi. Trimurthi dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Trimurthi.

Trimurthi Stock Index Membership - Nifty & Sensex

See which indices include Trimurthi stock. Check NOVELIX index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Trimurthi is not part of any tracked indices.
Only major market indices are tracked in our system.

Trimurthi Market Events Screener - Corporate Actions

Get Trimurthi corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Trimurthi stock events that may affect NOVELIX share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Extraordinary General Meeting dated July 1, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA -14.07%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 3.18%
2026-07-01 2026-07-01 Extraordinary General Meeting NA 28.90%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 7.61%
2026-02-12 2026-02-12 Quarterly Result Announcement NA -1.84%
2026-01-09 2026-01-09 Extraordinary General Meeting NA 2.02%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 5.72%
2025-09-19 2025-09-19 Annual General Meeting NA -1.76%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -0.62%
2025-05-27 2025-05-27 Quarterly Result Announcement NA 0.00%
2025-05-09 2025-05-09 Extraordinary General Meeting NA 0.00%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 4.97%
2024-11-18 2024-11-18 Extraordinary General Meeting NA 4.97%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 4.97%
2024-09-27 2024-09-27 Annual General Meeting NA 4.98%

Trimurthi Competitors Screener - Peer Stocks Comparison

Screen NOVELIX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 4 companies in the Retail sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Medplus Health Services 7,845 37.37 6,964 12.60% 220 40.52
Entero Healthcare Solutions 7,790 47.31 6,610 28.72% 146 57.43
Trimurthi 199 9 -4.17% -2 35.07
Vijaypd Ceutical 129 28.46 104 1.98% 5 50.17

Trimurthi Company Announcements - News & Reports Screener

Screen NOVELIX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 9, 2026.

The next most recent announcements are dated September 7, 2026 and September 7, 2026.

Date Update Actions
2026-09-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Announcement Under Regulation 30 (LODR)- Letter Of Annual Report & AGM Notice Weblink -
2026-09-07 Shareholders Meeting- Notice Of Annual General Meeting To Be Held On Wednesday 30Th September 2026. -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-08-31 Shareholders Meeting AGM On 30Th September 2026. -
2026-08-31 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-29 Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 29Th August 2026 -
2026-08-25 Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday 29Th August 2026 -
2026-08-20 Announcement Under Regulation 30 (LODR) - Lease Deed -
2026-08-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Compliances- Statement Of Deviation & Variation -
2026-08-13 Results- Financial Results For June 30 2026. -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th August 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. -
2026-08-09 Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 13Th August 2026. -
2026-07-16 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-13 Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 -
2026-07-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹66.23, within a 52-week range of ₹45.30 to ₹88.80. The P/E ratio is 15.00 and the P/B ratio is 5.63, with earnings per unit of ₹-2.22. Market capitalisation stands at ₹199.32 Cr. The company operates in the Retail sector, in the Pharmacy Retail industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.